BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 01/08/2023

FDA Clears Progesterone Injection for Sale After Review

The US Food and Drug Administration (FDA) has ruled that Progesterone Injection, USP, 50 mg/mL, will not be withdrawn from sale due to safety or effectiveness concerns, allowing the drug to continue being approved for use in abbreviated new drug applications (ANDAs).

Source: Federal Register — Food and Drug AdministrationOpen original release →